- Home
- IMUX vs TPIC Comparison
IMUX vs TPIC Comparison
Compare IMUX & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- TPIC
- Stock Information
- Founded
- IMUX 2016
- TPIC 1968
- Country
- IMUX United States
- TPIC United States
- Employees
- IMUX N/A
- TPIC N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- TPIC Industrial Machinery/Components
- Sector
- IMUX Health Care
- TPIC Industrials
- Exchange
- IMUX Nasdaq
- TPIC Nasdaq
- Market Cap
- IMUX 67.8M
- TPIC 58.4M
- IPO Year
- IMUX N/A
- TPIC 2016
- Fundamental
- Price
- IMUX $0.99
- TPIC $0.80
- Analyst Decision
- IMUX Strong Buy
- TPIC Hold
- Analyst Count
- IMUX 5
- TPIC 7
- Target Price
- IMUX $7.50
- TPIC $1.68
- AVG Volume (30 Days)
- IMUX 1.1M
- TPIC 479.9K
- Earning Date
- IMUX 08-07-2025
- TPIC 08-07-2025
- Dividend Yield
- IMUX N/A
- TPIC N/A
- EPS Growth
- IMUX N/A
- TPIC N/A
- EPS
- IMUX N/A
- TPIC N/A
- Revenue
- IMUX N/A
- TPIC $1,373,242,000.00
- Revenue This Year
- IMUX N/A
- TPIC $10.66
- Revenue Next Year
- IMUX N/A
- TPIC $6.52
- P/E Ratio
- IMUX N/A
- TPIC N/A
- Revenue Growth
- IMUX N/A
- TPIC 3.05
- 52 Week Low
- IMUX $0.56
- TPIC $0.64
- 52 Week High
- IMUX $2.11
- TPIC $5.15
- Technical
- Relative Strength Index (RSI)
- IMUX 57.59
- TPIC 40.72
- Support Level
- IMUX $0.90
- TPIC $0.85
- Resistance Level
- IMUX $1.18
- TPIC $0.91
- Average True Range (ATR)
- IMUX 0.08
- TPIC 0.08
- MACD
- IMUX 0.02
- TPIC 0.01
- Stochastic Oscillator
- IMUX 49.70
- TPIC 36.28
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.